On July 25, 2025, Phio Pharmaceuticals Corp. entered into agreements that allowed holders of existing warrants to exercise them for approximately $2.5 million, issuing new warrants in exchange. This transaction involved warrants for a total of up to 1.5 million shares at prices of $2.485 each.